137 Results
Sort By:
Published on July 23, 2020
The U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD) have ordered an initial 100 million doses the COVID-19 vaccine being developed by Pfizer and BioNTech for $1.95 billion, the companies said today—with the option to purchase 500 million additional doses. The companies agreed to offer…
Published on July 14, 2020
Endpoint Health—a new targeted therapeutics company that uses artificial intelligence—has announced its launch, with personalized treatments to help patients suffering from acute respiratory distress syndrome (ARDS) caused by COVID-19. The Palo Alto, Calif.-based company is already working with 40 top hospitals in the U.S. and abroad to bring personalized therapies…
Published on July 13, 2020
PerkinElmer is partnering with Sonora Quest Laboratories on an expansion of COVID-19 testing in Arizona, funded in part by the state of Arizona—which has acknowledged spikes in cases of the virus in late June and resulting growing demand for tests, though new-case numbers have declined in recent days. The state…
Published on July 8, 2020
Novavax announced on Tuesday that was awarded $1.6 billion for late-stage clinical trials and large-scale manufacturing to produce 100 million doses of its COVID-19 vaccine starting this year through President Donald Trump’s “Operation Warp Speed” program. The funding, Novavax said, will enable it to complete late-stage clinical studies aimed at…
Published on July 1, 2020
Sherlock Biosciences and binx health said today they intend to develop the world’s first rapid, point-of-care diagnostic test for COVID-19 leveraging CRISPR technology, through a strategic partnership whose value was not disclosed. The companies said they will combine the binx io diagnostic platform with SHERLOCKTM CRISPR technology in a test that will…
Published on June 29, 2020
Vaxart’s oral COVID-19 vaccine candidate has joined the handful of experimental vaccines being studied as part of President Donald Trump’s commitment to delivering 300 million vaccine doses protecting against SARS-CoV-2 by January 2021—while the company gears up to manufacture as many as one billion doses a year. The South San…
Published on June 17, 2020
The National Institutes of Health (NIH) plans to leverage the “significant and diverse participant base” found in its All of Us Research Program to study the spread and impact of COVID-19. The research will involve conducting antibody testing on thousands of participants, surveying them regarding their behaviors to prevent the…
Published on June 15, 2020
A consensus of experts has agreed that the U.S. needs much more COVID-19 testing than has been conducted as of mid-April, when The COVID Tracking Project tallied nearly 4.5 million total test results (4,493,106 as of 3:13 pm ET, April 23). However, far less agreement exists on how many more…
Published on June 12, 2020
Sequencing technology giant Illumina announced Wednesday that it received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Illumina COVIDSeq Test. The IVD workflow of Illumina’s diagnostic will allow labs to scale up testing to meet what is expected to be increased demand for…
Published on May 29, 2020
A consensus of experts has agreed that the U.S. needs much more COVID-19. As of today, according to Worldometer, there have been more than 16.3 million COVID-19 tests completed in the U.S. However, far less agreement exists on how many more tests are needed daily, order for federal, state, and…
Published on May 21, 2020
Sherlock Biosciences said today it will accelerate the development of its at-home COVID-19 diagnostic based on its INSPECTR platform—and work to develop additional tests to detect the disease in home and low-resource settings through its Sherlock Innovation Lab. The innovation lab, to be based in Cambridge, MA, will be funding…
Published on May 20, 2020
TruGenomix, a developer of next-generation genomic diagnostics for PTSD and other behavioral health conditions, will partner with BlueBee, the provider of a rapidly configurable omics data analysis platform, through a biomarker-based risk assessment collaboration focused on behavioral health that the companies said was hastened by the COVID-19 pandemic. According to…
Published on May 6, 2020
UK-based Iceni Diagnostics is developing a home-use SARS-CoV-2 diagnostic using glycan biology with the goal of having the test validated by autumn. Development of the hand-held device is being conducted at the University of East Anglia & John Innes Centre (JIC) spinout and supported by scientists at the Manchester Institute…
Published on April 30, 2020
A new initiative announced by the National Institutes of Health (NIH), backed by a $1.5 billion investment from federal stimulus funding, aims to speed innovation, development, and commercialization of COVID-19 testing technologies. Dubbed the Rapid Acceleration of Diagnostics (RADx) initiative the new program will infuse funding into early innovative technologies…
Published on April 23, 2020
The National Institute of Allergy and Infectious Diseases (NIAID) has today released its strategic plan to speed research aimed at diagnosing, preventing and treating COVID-19 which is responsible for the worst pandemic in more than 100 years. The plan include four priorities: Improve fundamental knowledge of SARS-CoV-2 and COVID-19 Develop…